Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
ConditioncGVHD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIncyte Corporation
About this trial
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Eligibility criteria
Qualifiers
Age ≥ 18 years inclusive at the time of signing the ICF
Allogeneic SCT 90 to 180 days prior to enrollment
Able to comprehend and willing to provide informed consent
Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel
Disqualifiers
There are no exclusion criteria for this study
Trial design
Treatments tested in this trial
- Non-Interventional
Treatment groups
1,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov